Concordance 3 references
Moderate To Severely Active Crohn's Disease
Found across 1 source type: Medications
π Medications
vedolizumab integrin receptor antagonist (gut-selective biologic)
vedolizumab βΊ integrin receptor antagonist (gut-selective biologic)
Open β
ustekinumab-gi IL-12/IL-23 inhibitor (monoclonal antibody)
ustekinumab (GI indication) βΊ IL-12/IL-23 inhibitor (monoclonal antibody)
Open β
adalimumab-gi TNF-alpha inhibitor
adalimumab (GI indication) βΊ TNF-alpha inhibitor
Open β